It's Time For Novartis To Put Its Leqvio Launch Strategy To The Test

 
• By Jessica Merrill

Novartis Pharmaceuticals US head Victor Bulto talks to Scrip about the launch of Leqvio; the cholesterol-lowering medicine now approved by the US FDA.

business project startup process, launching rocket, teamwork
Novartis projects a slow initial launch as it works to make sure treatment and reimbursement infrastructure is in place • Source: Alamy/Yuliya Volkovska

More from New Products

More from Scrip